Basit öğe kaydını göster

dc.contributor.authorKoyun, Efe
dc.contributor.authorKaradag, Remzi
dc.contributor.authorOzkanli, Seyma
dc.contributor.authorOgurtuzun, Serpil
dc.contributor.authorKocdogan, Arzu Kaya
dc.contributor.authorOzsoy, Isilay
dc.date.accessioned2021-01-14T18:10:59Z
dc.date.available2021-01-14T18:10:59Z
dc.date.issued2020
dc.identifier.citationKoyun, E., Karadag, R., Özkanlı, S. Ş., Oğuztüzün, S., Kocdogan, A. K., & Ozsoy, I. (2020). Caspase-3 p53 and Bcl-2 expression in basal cell carcinoma of the eyelid. Advances in Dermatology and Allergology, 37(4), 535–539.en_US
dc.identifier.issn1642-395X
dc.identifier.urihttps://doi.org/10.5114/ada.2020.98285
dc.identifier.urihttps://hdl.handle.net/20.500.12587/12843
dc.descriptionWOS:000565809700014en_US
dc.descriptionPubMed: 32994776en_US
dc.description.abstractIntroduction: Eyelid tumours mostly originated from skin and its appendeges. External carcinogens like UV radiation causes cell damages in the eyelid skin and contributes to carcinogenesis. Apoptosis is a very important mechanism to prevent these damage and probable neoplatic change. Aim: To compare caspase-3, p53 and Bcl-2 levels between patients with basal cell carcinoma (BCC) of the eyelid and healthy individuals. Material and methods: Pathology archives from October 2012 to April 2015 were scanned for BCC biopsies of the eyelid and tissue removed during blepharoplasty and entropion procedures. A total of 36 specimens were found. The specimens were divided into two groups: BCC group and controls (consisting of eyelid tissue removed during routine blepharoplasty). The pathology specimens were then stained using p53, Bcl-2 and caspase-3 stains and the intensity of staining was graded on a 0-3 scale. Results: Samples from a total of 36 patients were included in the study. Eighteen (50.0%) patients were female. There were 13 patients in the BCC group and 23 patients in the control group. The mean age was 66.0 +/- 10.8 years in the BCC group, and 65.61 +/- 11.22 years in the control group. The caspase-3 staining was lower in the BCC group than in the control group. No significant differences were found between the BCC group and the control group in terms of p53 levels or Bcl-2 levels (both of them, p = 1.000). Conclusions: The caspase-3 level was lower in the BCC group. This result suggests that these enzymes can play a significant role in carcinogenesis of eyelid BCC.en_US
dc.language.isoengen_US
dc.publisherTERMEDIA PUBLISHING HOUSE LTDen_US
dc.relation.isversionof10.5114/ada.2020.98285en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectbasal cell carcinomaen_US
dc.subjectBcl-2en_US
dc.subjectcaspase-3en_US
dc.subjecteyelid tumouren_US
dc.subjectimmunohistochemical stainen_US
dc.subjectp53en_US
dc.subjectmalignant tumouren_US
dc.titleCaspase-3, p53 and Bcl-2 expression in basal cell carcinoma of the eyeliden_US
dc.typearticleen_US
dc.contributor.departmentKKÜen_US
dc.identifier.volume37en_US
dc.identifier.issue4en_US
dc.identifier.startpage535en_US
dc.identifier.endpage539en_US
dc.relation.journalPOSTEPY DERMATOLOGII I ALERGOLOGIIen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster